Selected article for: "additional evidence and incubation period"

Author: Dhouib, Wafa; Maatoug, Jihen; Ayouni, Imen; Zammit, Nawel; Ghammem, Rim; Fredj, Sihem Ben; Ghannem, Hassen
Title: The incubation period during the pandemic of COVID-19: a systematic review and meta-analysis
  • Cord-id: cfn3ywb4
  • Document date: 2021_4_8
  • ID: cfn3ywb4
    Snippet: BACKGROUND: The aim of our study was to determine through a systematic review and meta-analysis the incubation period of COVID-19. It was conducted based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA). Criteria for eligibility were all published population-based primary literature in PubMed interface and the Science Direct, dealing with incubation period of COVID-19, written in English, since December 2019 to December 2020. We estimated the mean of the incubat
    Document: BACKGROUND: The aim of our study was to determine through a systematic review and meta-analysis the incubation period of COVID-19. It was conducted based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA). Criteria for eligibility were all published population-based primary literature in PubMed interface and the Science Direct, dealing with incubation period of COVID-19, written in English, since December 2019 to December 2020. We estimated the mean of the incubation period using meta-analysis, taking into account between-study heterogeneity, and the analysis with moderator variables. RESULTS: This review included 42 studies done predominantly in China. The mean and median incubation period were of maximum 8 days and 12 days respectively. In various parametric models, the 95th percentiles were in the range 10.3–16 days. The highest 99th percentile would be as long as 20.4 days. Out of the 10 included studies in the meta-analysis, 8 were conducted in China, 1 in Singapore, and 1 in Argentina. The pooled mean incubation period was 6.2 (95% CI 5.4, 7.0) days. The heterogeneity (I(2) 77.1%; p < 0.001) was decreased when we included the study quality and the method of calculation used as moderator variables (I(2) 0%). The mean incubation period ranged from 5.2 (95% CI 4.4 to 5.9) to 6.65 days (95% CI 6.0 to 7.2). CONCLUSIONS: This work provides additional evidence of incubation period for COVID-19 and showed that it is prudent not to dismiss the possibility of incubation periods up to 14 days at this stage of the epidemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-021-01648-y.

    Search related documents:
    Co phrase search for related documents
    • abstract title and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • abstract title and additional file: 1
    • abstract title and longitudinal study: 1, 2, 3, 4
    • active monitoring and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • active monitoring and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • active monitoring and additional evidence: 1
    • active monitoring and additional file: 1
    • active monitoring and log distribution: 1
    • active monitoring and log normal: 1
    • active monitoring and log normal distribution: 1
    • active monitoring and long incubation period: 1, 2
    • acute respiratory syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and additional file: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and log distribution: 1, 2, 3
    • acute respiratory syndrome and log normal: 1, 2, 3
    • acute respiratory syndrome and log normal distribution: 1
    • acute respiratory syndrome and long incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute respiratory syndrome and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and additional file: 1, 2, 3, 4, 5, 6, 7, 8, 9